VEA
MRSN

Virtus ETF Advisers’s Mersana Therapeutics MRSN Stock Holding History

Virtus ETF Advisers’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-414
Closed -$13.2K – 453
2023
Q3 		$13.2K Sell
414
-41
-9% -$1.95K 0.01% 432
2023
Q2 		$37.5K Sell
455
-112
-20% -$16.4K 0.02% 433
2023
Q1 		$58.2K Sell
567
-218
-28% -$30.6K 0.03% 424
2022
Q4 		$115K Sell
785
-617
-44% -$104K 0.06% 429
2022
Q3 		$237K Buy
1,402
+10
+0.7% +$1.63K 0.09% 297
2022
Q2 		$161K Buy
1,392
+260
+23% +$24.5K 0.06% 314
2022
Q1 		$113K Sell
1,132
-67
-6% -$7.83K 0.05% 282
2021
Q4 		$186K Buy
1,199
+632
+111% +$123K 0.07% 236
2021
Q3 		$134K Sell
567
-29
-5% -$8.47K 0.06% 359
2021
Q2 		$203K Buy
596
+125
+27% +$47.3K 0.08% 335
2021
Q1 		$190K Buy
471
+9
+2% +$4.37K 0.08% 332
2020
Q4 		$308K Sell
462
-157
-25% -$87.3K 0.13% 201
2020
Q3 		$288K Sell
619
-84
-12% -$42.4K 0.15% 232
2020
Q2 		$411K Buy
+703
New +$240K 0.19% 188

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return